Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHEN
Maria Pilar Ballester, Rocío Gallego-Durán, Shalimar, Karen Louise Thomsen, Constantine J Karvellas, Srinivasan Dasarathy, Debbie L Shawcross, Dominique Thabut, Jinjun Chen, Christopher F Rose, Rajiv Jalan
Access here (J Hepatol. 2026 Mar 20:S0168-8278(26)00146-7)
The dual roles of natural killer cells in liver immunity and tolerance: Implications for health and disease
Zhongheng Li, Yihang Gong, Linsen Ye, Wei Liu
Access here (Hepatol Commun. 2026 Mar 11;10(4):e00923)
Acute-on-chronic liver failure and immune dysregulation: Systemic inflammation and immunoparesis paradox
Abigail A Drago, Sarah Yanofsky, Ramsey Rohner, Kamal Baral, Leah Spade, Peng-Sheng Ting, Bilon Khambu
Access here (Hepatol Commun. 2026 Mar 11;10(4):e00917)
Ileal Bile Acid Transporter Inhibitors in Cholestasis: Potential for More Than Just Paediatrics?
Mahesh Krishna, James Lorenzen Boyer
Access here (Liver Int. 2026 Mar;46(3):e70524)
PIEZO1 channel mechanosensing in hepatobiliary physiology and disease
Charalampos Konstantinou, Shaili K Patel, Patricia Lalor, J Bernadette Moore, Lee D Roberts, Naima Endesh, Tze M Wah, Adel Samson, Abdul R Hakeem, Kondragunta R Prasad, David J Beech, Laeticia Lichtenstein
Access here (Am J Physiol Cell Physiol. 2026 Feb 1;330(2):C421-C433)
Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications
Zihan Wang, Zixuan Cao, Yunsheng Dong, Yi Hong, Li Zuo, Hua Wang
Access here (Hepatol Commun. 2026 Jan 21;10(2):e0893)
Massive hepatic necrosis-associated acute liver failure
Tao Lin, Chenhao Tong, Roman Liebe, Honglei Weng
Access here (eGastroenterology. 2026 Jan 9;4(1):e100217)
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological Diseases
Sophia Heinrich, Andreia Margarida Carvalho de Matos, Jordi Colmenero, Ahmed M Elsharkawy, Soňa Fraňková, Jan Halbritter, Anna Mrzljak, Roman-Ulrich Müller, Rafaela Pereira, Pavel Strnad, Carmen A J Teemer, Jef Verbeek, Karolina M Wronka, Frederik Nevens, Richard Taubert, Joost P H Drenth; European Reference Network on Hepatological Liver Diseases (ERN RARE‐LIVER)
Access here (Liver Int. 2026 Jan;46(1):e70451)
Liver as a key organ for systemic antimicrobial defense
Tiantian Yao, Luca Maccioni, Yukun Guan, Robim M Rodrigues, Bin Gao
Access here (Hepatol Commun. 2025 Dec 1;9(12):e0814)
EASL Clinical Practice Guidelines on vascular diseases of the liver
European Association for the Study of the Liver
Access here (J Hepatol. 2025 Nov 12:S0168-8278(25)02406-7)
The role of Liver Sinusoidal Endothelial Cells in liver diseases: key players in health and pathology
Eric Felli, Yeldos Nulan, Martí Ortega-Ribera, Anabel Fernández-Iglesias, Jordi Gracia-Sancho
Access here (J Hepatol. 2025 Oct 24)
Haemostatic Balance and Transfusion Strategies in Acute Liver Failure and Acute-On-Chronic Liver Failure: A Systematic Review
Kymentie Ferdinande, Elena Campello, Paolo Simioni, Alberto Zanetto, Marco Senzolo
Access here (Liver Int. 2025 Nov;45(11):e70378)
Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies
Giorgio Cazzaniga, Francesca Bolis, Chiara Caime, Rocco Piazza, Laura Žigutytė, Jakob Nikolas Kather, Fabio Pagni, Pietro Invernizzi, Marco Carbone, Alessio Gerussi
Access here (Liver Int. 2025 Nov;45(11):e70377)
Cellular Senescence in Liver Diseases: From Molecular Drivers to Therapeutic Targeting
Kuo Du, David S Umbaugh, Niansheng Ren, Anna Mae Diehl
Access here (J Hepatol. 2025 Aug 27:S0168-8278(25)02454-7)
Myeloid cells in chronic liver inflammation
Dimitrios Patseas, Ahmed El-Masry, Zuobin Liu, Prakash Ramachandran, Evangelos Triantafyllou
Access here (Cell Mol Immunol. 2025 Jul 28)
Pathogenesis, Non-Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases
Ellina Lytvyak, Gideon Hirschfield, Devika Shreekumar, Yu Jun Wong, Aldo J Montano-Loza
Access here (Liver Int. 2025 Aug;45(8):e70190)
Communication initiated by hepatocytes: The driver of HSC activation and liver fibrosis
Ruichao Lan, Jun Lin, Shuai Chen, Zhi Lu, Yihang Gong, Siwei Tan, Xianzhi Liu, Weiling He
Access here (Hepatol Commun. 2025 Jul 14;9(8):e0753)
Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease
Michael Trauner, Saul J Karpen, Paul A Dawson
Access here (Hepatology. 2025 Jul 2)
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells
Enis Kostallari, Robert F Schwabe, Adrien Guillot
Access here (Cell Mol Immunol. 2025 Jul 1)
Chimeric Antigen Receptor (CAR) T-cell Therapy: Engineering Immune Cells To Treat Liver Diseases
Elmar Jaeckel, Scott L Friedman, Michael Hudecek, Ulrike Protzer
Access here (J Hepatol. 2025 Jun 20:S0168-8278(25)02274-3)
Enteronephrohepatic Circulation of Bile Acids and Therapeutic Potential of Systemic Bile Acid Transporter Inhibitors
Ahmed Ghallab, Mattias Mandorfer, Guido Stirnimann, Joachim Geyer, Erik Lindström, Tom Luedde, Schalk van der Merwe, Jassin Rashidi-Alavijeh, Hartmut Schmidt, Saul J Karpen, Peter Fickert, Michael Trauner, Jan G Hengstler, Paul A Dawson
Access here (J Hepatol. 2025 May 23:S0168-8278(25)02207-X)
Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders
Subhadip Choudhuri, Nisha Jain Garg
Access here (Liver Int. 2025 Jun;45(6):e16245)
Role of mitogens in normal and pathological liver regeneration
Massoud Vosough, Bahare Shokouhian, Mohammad Amin Sharbaf, Roya Solhi, Zahra Heidari, Homeyra Seydi, Moustapha Hassan, Ezhilarasan Devaraj, Mustapha Najimi
Access here (Hepatol Commun. 2025 Apr 30;9(5):e0692)
Natural History of Idiosyncratic Drug-Induced Liver Injury and Prognostic Models
Harshad C Devarbhavi, Raúl J Andrade
Access here (Liver Int. 2025 Jun;45(6):e70138)
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
European Association for the Study of the Liver
Access here (J Hepatol. 2025 May 10:S0168-8278(25)00173-4)
Portal sinusoidal vascular diseases: Assessment and therapy
Maria Mironova, Harish Gopalakrishna, Christopher Koh, David E Kleiner, Theo Heller
Access here (Hepatology. 2025 Apr 4)
Cell therapies and liver organogenesis technologies: Promising strategies for end-stage liver disease
Shaoyang Qin, Xiaochen Bo, Hongyuan Liu, Zhishuo Zhang, Zhicong Zhao, Qiang Xia
Access here (Hepatology. 2025 Apr 3)
Advances in imaging – Elastography
Elton Dajti, Adrian T Huber, Giovanna Ferraioli, Annalisa Berzigotti
Access here (Hepatology. 2025 Apr 2)
Unravelling the Role of PANoptosis in Liver Diseases: Mechanisms and Therapeutic Implications
Wanyuan Xiong, Junfeng Li, Aiping Tian, Xiaorong Mao
Access here (Liver Int. 2025 Apr;45(4):e70000)
Regulatory T cell therapy in autoimmune liver disease and transplantation
M Fleming, A Sanchez-Fueyo, N Safinia
Access here (JHEP Rep. 2025 Mar)
Hot and Cold Fibrosis: The Role of Serum Biomarkers to assess the Immune Mechanisms and ECM-Cell Interactions in Human Fibrosis
A Zawadzki, D J Leeming, A J Sanyal, Q M Anstee, J M Schattenberg, S L Friedman, S D Schuppan, M A Karsdal
Access here (J Hepatol. 2025 Mar 6:S0168-8278(25)00148-5)
Peroxisome proliferator-activated receptor delta and liver diseases
Tomoo Yamazaki, Edward E Cable, Bernd Schnabl
Access here (Hepatol Commun. 2025 Feb 3;9(2):e0646)
Neurogastroenterology and motility disorders in patients with cirrhosis
Francisco Idalsoaga, Gustavo Ayares, Hanna Blaney, Daniel Cabrera, Javier Chahuan, Hugo Monrroy, Ayah Matar, Houssam Halawi, Marco Arrese, Juan Pablo Arab, Luis Antonio Díaz
Access here (Hepatol Commun. 2025 Jan 7;9(1):e0622)
The evolving role of liver biopsy: Current applications and future prospects
Purva Gopal, Xiaobang Hu, Marie E Robert, Xuchen Zhang
Access here (Hepatol Commun. 2025 Jan 7;9(1):e0628)
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects
Vincenzo Ronca, Scott P Davies, Ye Htun Oo, Ana Lleo
Access here (Hepatology. 2025 Jan 3)
Thyroid hormone and the Liver
Lorraine Soares De Oliveira, Megan J Ritter
Access here (Hepatol Commun. 2024 Dec 20;9(1):e0596)
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress
Colleen M Hayes, Gina M Gallucci, James L Boyer, David N Assis, Nisanne S Ghonem
Access here (Hepatol Commun. 2024 Dec 20;9(1):e0612)
Key role of macrophages in the progression of hepatic fibrosis
Jinqiu Ran, Shengxia Yin, Rahma Issa, Qianwen Zhao, Guangqi Zhu, Huan Zhang, Qun Zhang, Chao Wu, Jie Li
Access here (Hepatol Commun. 2024 Dec 11;9(1):e0602)
